scholarly article | Q13442814 |
P2093 | author name string | Goldberg J | |
Gottlieb AJ | |||
Preisler HD | |||
Brennan J | |||
Rai K | |||
Winton EF | |||
Miller KB | |||
Browman G | |||
Vogler WR | |||
Grunwald H | |||
P433 | issue | 4 | |
P921 | main subject | cytarabine | Q180983 |
P304 | page(s) | 455-459 | |
P577 | publication date | 1986-04-01 | |
P1433 | published in | Cancer Treatment Reports | Q27710285 |
P1476 | title | Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study | |
P478 | volume | 70 |
Q37717088 | Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens |
Q46274818 | Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation |
Q44503375 | Five-day 4'-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia |
Q33383996 | High-dose ara-C and etoposide in refractory or relapsing acute leukemia |
Q37904928 | The toxicity of cytarabine |
Q37909059 | Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment |